blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1933150

EP1933150 - Screening for peptides inhibiting PP1c binding to BcI-2, BCL-XL and BCL-W proteins [Right-click to bookmark this link]
Former [2008/25]Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof
[2008/26]
StatusNo opposition filed within time limit
Status updated on  29.04.2011
Database last updated on 19.07.2024
Most recent event   Tooltip11.10.2013Lapse of the patent in a contracting state
New state(s): ES		published on 13.11.2013  [2013/46]
Applicant(s)For all designated states
INSTITUT PASTEUR
25-28, rue du Docteur Roux
75724 Paris Cedex 15 / FR
[2008/25]
Inventor(s)01 / Garcia, Alphonse
Villa du Théâtre 37 rue Molière
792120 Montrouge / FR
02 / Cayla, Xavier
11 rue Raphaël L. Pouan
37210 Rochecorbon / FR
03 / Rebollo, Angelita
21, square Jean Thébaud
75015 Paris / FR
 [2008/45]
Former [2008/25]01 / Garcia, Alphonse
Villa du Théâtre 37 rue Molière
792120 Montrouge / FR
02 / Cayla, Xavier
11 rue Raphaël L. Pouan
37210 Rochecorbon / FR
03 / Rebollo, Angelita
21, square Jean Thébaud
75015 Paris / FR
Representative(s)Desaix, Anne, et al
Ernest Gutmann - Yves Plasseraud S.A.S.
66, rue de la Chaussée d'Antin
75009 Paris / FR
[N/P]
Former [2008/45]Desaix, Anne, et al
Ernest Gutmann - Yves Plasseraud S.A.S. 3, rue Auber
75009 Paris / FR
Former [2008/25]Desaix, Anne
Ernest Gutmann - Yves Plasseraud S.A.S. 3, rue Auber
75009 Paris / FR
Application number, filing date07025179.806.05.2003
[2008/25]
Priority number, dateEP2002029117007.05.2002         Original published format: EP 02291170
[2008/25]
Previously filed application, dateEP2003074989406.05.2003
[2008/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1933150
Date:18.06.2008
Language:EN
[2008/25]
Type: B1 Patent specification 
No.:EP1933150
Date:23.06.2010
Language:EN
[2010/25]
Search report(s)(Supplementary) European search report - dispatched on:EP16.05.2008
ClassificationIPC:G01N33/68, C07K7/06, C07K7/08, C07K16/44, G01N33/50, C12N15/11, A61K48/00
[2008/25]
CPC:
C07K7/08 (EP,US); A61K38/1709 (EP,US); A61P25/00 (EP);
A61P25/16 (EP); A61P25/28 (EP); A61P3/10 (EP);
A61P31/00 (EP); A61P31/12 (EP); A61P31/18 (EP);
A61P9/12 (EP); C07K14/4747 (EP,US); C07K16/18 (EP,US);
C07K7/06 (EP,US); C12N9/16 (EP,US); C40B30/04 (EP,US);
G01N33/505 (EP,US); G01N33/6842 (EP,US); G01N33/6845 (EP,US);
G01N2333/916 (EP,US); G01N2500/02 (EP,US); G01N2500/04 (EP,US);
G01N2500/10 (EP,US); G01N2500/20 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2008/25]
TitleGerman:Screeningverfahren für Peptide, die die Bindung von PP1c an die Proteine Bcl-2, BCL-XL und BCL-W hemmen[2008/26]
English:Screening for peptides inhibiting PP1c binding to BcI-2, BCL-XL and BCL-W proteins[2008/26]
French:Procédés d'analyse, de peptides inhibiteurs de la liaison de PP1c avec des protéines Bcl-2, BCL-XL et BCL-W[2008/26]
Former [2008/25]Screeningverfahren für PP1-wechselwirkende Polypeptide oder Proteine, Peptide, die die Bindung von PP1c an die Proteine Bcl-2, BCL-XL und BCL-W hemmen, und ihre Verwendung
Former [2008/25]Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof
Former [2008/25]Procédés d'analyse de polypeptides ou de protéines interagissant avec PP1, de peptides inhibiteurs de la liaison de PP1c avec des protéines Bcl-2, BCL-XL et BCL-W, et utilisations de ceux-ci
Examination procedure04.12.2008Examination requested  [2009/03]
14.05.2009Despatch of a communication from the examining division (Time limit: M04)
10.09.2009Reply to a communication from the examining division
29.01.2010Communication of intention to grant the patent
23.04.2010Fee for grant paid
23.04.2010Fee for publishing/printing paid
Parent application(s)   TooltipEP03749894.6  / EP1502116
Opposition(s)24.03.2011No opposition filed within time limit [2011/22]
Fees paidRenewal fee
28.12.2007Renewal fee patent year 03
28.12.2007Renewal fee patent year 04
28.12.2007Renewal fee patent year 05
21.03.2008Renewal fee patent year 06
20.04.2009Renewal fee patent year 07
16.04.2010Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
HU23.06.2010
IT23.06.2010
NL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
BG23.09.2010
GR24.09.2010
ES04.10.2010
PT25.10.2010
[2013/46]
Former [2013/45]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
HU23.06.2010
IT23.06.2010
NL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
BG23.09.2010
GR24.09.2010
PT25.10.2010
Former [2013/44]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
BG23.09.2010
GR24.09.2010
PT25.10.2010
Former [2013/42]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
BG23.09.2010
GR24.09.2010
PT25.10.2010
Former [2011/20]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
DK23.06.2010
EE23.06.2010
FI23.06.2010
IT23.06.2010
NL23.06.2010
RO23.06.2010
SE23.06.2010
SI23.06.2010
SK23.06.2010
GR24.09.2010
PT25.10.2010
Former [2011/06]AT23.06.2010
FI23.06.2010
SE23.06.2010
SI23.06.2010
GR24.09.2010
Documents cited:Search[DA]  - AYLLÓN V ET AL, "Bcl-2 targets protein phosphatase 1 alpha to Bad.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.: 1950) UNITED STATES 15 JUN 2001, (20010615), vol. 166, no. 12, ISSN 0022-1767, pages 7345 - 7352, XP002218405 [DA] 1-18 * the whole document *
 [A]  - FERNANDEZ JOSE A ET AL, "Analysis of protein S C4b-binding protein interactions by homology modeling and inhibitory antibodies.", BIOCHEMISTRY, (1994), vol. 33, no. 37, ISSN 0006-2960, pages 11073 - 11078, XP002218407 [A] 1-18 * abstract *

DOI:   http://dx.doi.org/10.1021/bi00203a003
 [A]  - FUKUDA M N ET AL, "A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (20000115), vol. 60, ISSN 0008-5472, pages 450 - 456, XP002210449 [A] 1-18 * abstract *
 [T]  - AYLLON VERONICA ET AL, "The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad.", EUROPEAN JOURNAL OF IMMUNOLOGY, (20020613), vol. 32, no. 7, ISSN 0014-2980, pages 1847 - 1855, XP002218406 [T] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7
by applicantEP0171496
 EP0184187
 WO8702671
 US4946778
 US4980286
 WO9308829
 US5258498
    - MERRIFIELD, ADV. ENZMOL. RELATED AREAS MOL. BIOL., (1969), vol. 32, pages 221 - 96
    - MERRFIELD, RECENT PROG. HORM. RES, (1967), vol. 23, pages 451 - 82
    - GOLDSPIEL ET AL., CLIN. PHARM., (1993), vol. 12, pages 488 - 505
    - ROBBINS ET AL, PHARMACOL. THER., (1998), vol. 80, no. 1, pages 35 - 47
    - MILLER ET AL., METH. ENZYMOL., (1993), vol. 217, pages 581 - 599
    - KOHLER; MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497
    - KOZBOR ET AL., IMMUNOLOGY TODAY, (1983), vol. 4, page 72
    - COLE, Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, INC., (1985), pages 77 - 96
    - JESPERS ET AL., BIO/TECHNOLOGY, (1994), vol. 12, pages 899 - 903
    - HUSTON ET AL., METHODS IN ENZYMOLOGY, (1991), vol. 203, pages 46 - 88
    - SHU ET AL., PNAS, (1993), vol. 90, pages 7995 - 7999
    - SKERRA ET AL., SCIENCE, (1988), vol. 240, pages 1038 - 1040
    - MILSTEIN ET AL., NATURE, (1983), vol. 305, pages 537 - 539
    - TRAUNECKER ET AL., EMBO J., (1991), vol. 10, pages 3655 - 3659
 WO1990US02545
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.